Table 1.
The characteristics of the study sample.
|
| |
|---|---|
| VARIABLES | FINDINGS |
|
| |
| Age (years) | 63 ± 11.25 |
|
| |
| PI-RADS score | |
|
| |
| PI-RADS 4 | 31 (43%) |
|
| |
| PI-RADS 5 | 41 (57%) |
|
| |
| Lesion zone | |
|
| |
| Peripheral | 60 (83%) |
|
| |
| Transitional | 12 (17%) |
|
| |
| Gleason score | |
|
| |
| 3+4 | 44 (61%) |
|
| |
| 4+3 | 19 (26%) |
|
| |
| 4+4 | 1 (1%) |
|
| |
| 4+5 | 8 (11%) |
|
| |
| Prostate volume on MRI (cm3) | 37.26 ± 16.34 |
|
| |
| Prostate volume on pathology (ml) | 45 ± 15 |
|
| |
| PSA level (ng/ml) | 7.08 ± 5.02 |
|
| |
| PSA density (ng/ml2) | 0.14 ± 0.12 |
|
| |
| Endorectal coil | 39 (54%) |
|
| |
PI-RADS: Prostate Imaging Reporting & Data System; MRI: Magnetic Resonance Imaging; PSA: Prostate Specific Antigen.